U.S. Medical Equipment Stock News

Goldman Sachs Group (GS) is back in focus after regulators revised the Basel III framework, easing capital requirements for major banks, while commentary points to a projected pickup in mergers and acquisitions activity in 2026. See our latest analysis for Goldman Sachs Group. Goldman Sachs shares recently caught a bid on the Basel III revision and expectations for heavier M&A pipelines. While the 90 day share price return of 5.61% is weak, the 1 year total shareholder return of 72.31% and 5...

In March 2026, Intapp announced that Am Law 200 firm Buchanan Ingersoll & Rooney migrated Intapp Time to the cloud and adopted Intapp Terms to modernize timekeeping and strengthen compliance with client guidelines across matters. This win underscores growing demand among large professional services firms for AI-enabled, compliance-focused billing tools that streamline workflows and reduce manual data entry. We’ll now examine how Buchanan’s adoption of Intapp’s AI-powered cloud timekeeping...

In the recent past, Capital Southwest reported a very strong quarter, beating analysts’ revenue and EPS estimates and originating about US$244 million of new and follow-on investments across eight new and 16 existing portfolio companies. This performance placed Capital Southwest among the better-performing specialty finance names for the quarter, underlining healthy deal flow and active portfolio deployment. Now we’ll explore how this stronger-than-expected quarter, particularly the US$244...

Event context and recent share performance Kinsale Capital Group (KNSL) has recently drawn investor attention after a period of weaker share performance, with the stock showing a 12% decline over the past month and a similar move over the past 3 months. See our latest analysis for Kinsale Capital Group. Against this recent pullback, Kinsale Capital Group’s 1 year total shareholder return of a 30.7% decline contrasts with a 3 year total shareholder return of 13.26% and a 5 year total...

Multiple securities fraud lawsuits have been filed against Corcept Therapeutics (NasdaqCM:CORT), alleging the company misled investors about FDA concerns and trial efficacy for relacorilant. Plaintiffs claim Corcept did not fully disclose FDA reservations about the adequacy of clinical data before a Complete Response Letter declined approval for a specific indication. The FDA decision was followed by a sharp share price drop and a wave of class action filings from several law firms. The...

If you are wondering whether Unum Group's current share price reflects its underlying value, this breakdown aims to put the recent numbers and valuation signals into clear context. The stock last closed at US$74.17, with returns of 5.0% over 30 days, a 4.0% decline year to date, and a 4.2% decline over the past year. The 3 year and 5 year returns sit at 107.2% and 219.5% respectively. Recent coverage of Unum Group has focused on its position within the US insurance sector and how investors...

What is driving MasTec’s latest surge in attention? Recent analyst upgrades, heavier institutional buying, and a run of positive brokerage ratings have pushed MasTec (MTZ) into the spotlight. Many investors are reassessing the contractor’s infrastructure focused business model and recent share performance. See our latest analysis for MasTec. Their recent 0.7% 1 day share price return, 9.6% 7 day share price return, and 47.7% year to date share price return, alongside a 200.2% 1 year total...

KKR (NYSE:KKR) is leading a $90 million Series C funding round in Coder, a provider of secure AI software development infrastructure. The firm has also closed a record $23 billion North America private equity fund in a challenging fundraising climate. KKR, trading at $91.23, sits at the center of two important themes for investors: large scale private equity capital and AI focused infrastructure. The stock shows mixed return patterns, with a 3 year gain of 89.2% and a 5 year gain of 84.5%,...

Recognition as a Top Community Bank Puts German American Bancorp in Focus German American Bancorp (GABC) has drawn fresh attention after ranking #29 among 223 community banks in S&P Global Market Intelligence’s 2025 performance review for institutions with $3b to $10b in assets. The recognition highlights how the Jasper, Indiana based bank’s operations and financial profile compare with peers. It also provides investors with another reference point as they consider the stock’s recent returns...

On March 30, 2026, Fortune Brands Innovations, Inc. filed a definitive proxy statement urging shareholders to vote against a proposal from investor John Chevedden that would reorganize the Board so every director stands for election at each annual meeting, ahead of the May 5, 2026 shareholder meeting. This board-structure debate highlights growing shareholder focus on Fortune Brands’ corporate governance and director accountability, adding a new dimension to how investors may assess the...

If you are wondering whether EastGroup Properties at around US$188 per share is offering good value today, it helps to first separate price action from underlying worth. Over the last week the stock returned 2.4%, while the 30 day return was a 3.6% decline, and over 1 year it recorded a 17.6% return, which can change how you think about both upside potential and risk. Recent coverage of EastGroup Properties has focused on its position as an industrial REIT and how investors are weighing that...

For investors asking whether Sherwin-Williams at around US$318 a share represents fair value, a bargain, or a premium price, this article looks directly at what the numbers indicate about the stock. The share price closed at US$318.00, with a 0.5% decline over 7 days, an 8.8% decline over 30 days, a 3.0% decline year to date, and a 5.8% decline over 1 year. The 3 year and 5 year returns stand at 45.8% and 31.1% respectively. These mixed returns put valuation in the spotlight as investors...

If you are wondering whether Enterprise Products Partners at around US$37.57 still offers value, the key question is how its current price compares with what investors are actually getting. The unit price has seen mixed short term moves, with a 3.9% decline over the last 7 days, a 0.5% return over the past month, and stronger returns of 16.8% year to date and 20.2% over the last year. Recent coverage has focused on Enterprise Products Partners as a large midstream energy name that some...

The United States market has experienced a positive trend, with a 1.9% increase over the last week and a substantial 24% rise over the past year, while earnings are projected to grow by 15% annually in the coming years. In such an environment, identifying stocks that are potentially undervalued can be appealing to investors seeking opportunities for growth, especially when there is notable insider activity suggesting confidence in these companies' prospects.

The United States market has shown robust performance recently, climbing 1.9% in the last week and achieving a remarkable 24% increase over the past year, with earnings projected to grow by 15% annually in the coming years. In such a dynamic environment, identifying high growth tech stocks involves focusing on companies that demonstrate strong innovation potential and scalability to capitalize on these favorable conditions.

The United States market has shown robust performance, rising 1.9% over the last week and 24% over the past year, with earnings projected to grow by 15% annually. In such an environment, identifying stocks that are potentially undervalued can offer investors opportunities to capitalize on discrepancies between a company's intrinsic value and its current market price.

The United States market has shown robust performance, climbing 1.9% in the last week and achieving a 24% increase over the past year, with earnings projected to grow by 15% annually. In this thriving environment, growth stocks with strong insider ownership can be particularly appealing as they often indicate confidence from those closest to the company's operations and future prospects.

Over the last 7 days, the market has risen 1.9%, and it is up 24% over the last 12 months, with earnings expected to grow by 15% per annum over the next few years. Penny stocks may be a throwback term, but they still represent opportunities for growth at lower price points when backed by strong balance sheets and solid fundamentals. In this article, we explore several high-quality penny stocks that stand out as hidden gems with potential for impressive returns.

The United States market has shown positive momentum recently, with a 1.9% increase over the last week and a notable 24% climb in the past year, alongside forecasts of 15% annual earnings growth. In such an environment, dividend stocks like CB Financial Services can offer investors potential income stability and growth opportunities, making them worth considering for those seeking to balance risk and reward in their portfolios.

What Alkermes stock’s recent move might mean for investors Alkermes (ALKS) has drawn fresh attention after its shares moved around recent trading, with a last close of $34.84 and positive returns over the week, month, and past 3 months. See our latest analysis for Alkermes. The recent 7 day share price return of 16.44% and 30 day return of 19.32% sit alongside a 5 year total shareholder return of 85.87%. Together, these figures indicate that momentum has been present over both shorter and...

Recent share performance and what it might signal Becton Dickinson (BDX) has seen its share price under pressure, with a 1 day return of 1.17%, a 7 day return of 1.82%, about an 11% decline over the past month and roughly a 21% decline over the past 3 months. Over longer periods, total returns show about a 9% decline over the past year, around 18% over 3 years and roughly 10% over 5 years, setting the backdrop for how investors might view the current valuation. See our latest analysis for...

Clorox (NYSE:CLX) has completed its acquisition of GOJO Industries, the maker of Purell. The deal adds the Purell brand to Clorox's portfolio of cleaning and disinfecting products. This transaction expands Clorox's footprint in health and hygiene solutions across consumer and B2B channels. For you as an investor, this move puts Clorox deeper into everyday hygiene habits at workplaces, healthcare facilities, and at home. The company already has a presence in cleaning and disinfecting, and...

Hesai Group (HSAI) has drawn fresh investor attention after reporting GAAP profitability for 2025, signing a new supply framework with Sharpa for LiDAR and robotics, and attracting constructive analyst coverage. See our latest analysis for Hesai Group. Hesai’s recent earnings, new Sharpa framework and analyst interest arrive after a mixed stretch in the market, with a 7 day share price return of 6.4% but a 30 day share price return decline of 17.6%, while the 1 year total shareholder return...

If you are wondering whether IDACORP at around US$144.27 is still a sensible entry or hold for you, this valuation breakdown is designed to help you frame that question clearly. The stock has logged returns of 3.4% over the last week, 0.4% over the last month, 13.3% year to date and 23.9% over the last year, with longer term figures of 42.6% over three years and 68.1% over five years. Recent market attention has kept IDACORP on the radar for investors looking at regulated utilities and...